Next Article in Journal
Epigenetic Regulation of Innate Immunity by microRNAs
Previous Article in Journal
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
Article Menu

Export Article

Open AccessArticle
Antibodies 2016, 5(2), 7; doi:10.3390/antib5020007

Development and Characterization of New Species Cross-Reactive Anti-Sialoadhesin Monoclonal Antibodies

1
Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp (UA), Antwerp 2610, Belgium
2
Laboratory of Virology, Ghent University, Merelbeke 9820, Belgium
3
Inflammation Research Center, VIB-Department of Internal Medicine, Ghent University, Ghent 9000, Belgium
4
Laboratory of Cell Biology and Histology, University of Antwerp (UA), Antwerp 2020, Belgium
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Mark Cragg
Received: 25 January 2016 / Revised: 3 March 2016 / Accepted: 14 March 2016 / Published: 23 March 2016
View Full-Text   |   Download PDF [1980 KB, uploaded 23 March 2016]   |  

Abstract

Sialoadhesin (Sn) is a surface receptor expressed on a subset of macrophages in steady state conditions. During inflammation and diseases, Sn is highly upregulated on macrophages and blood monocytes. Therefore, therapies using monoclonal antibodies (mAbs) to target Sn-positive (Sn+) cells are a potential strategy for targeted treatment. It has been shown that Sn internalizes after binding with a mAb, though it is not clear whether this is species-specific. In this study, new Sn-specific mAbs were developed and analyzed for cross-reactivity between species. In addition, the newly developed mAbs were compared to mAbs used in previous research for their epitope recognition and other Sn-specific characteristics. Both species-specific and cross-reactive antibodies could be identified. Furthermore, sialic acid-binding of red blood cells (RBC) could be inhibited with mAbs recognizing different epitopes and all mAb showed internalization of Sn. The newly developed mAbs can be used as novel tools for Sn research and further analysis of Sn internalization in different species. View Full-Text
Keywords: sialoadhesin; monoclonal antibody; internalization sialoadhesin; monoclonal antibody; internalization
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

De Schryver, M.; Van Gorp, H.; Hoebeke, I.; De Maeyer, B.; Ooms, K.; Pintelon, I.; Maes, L.J.; Cos, P.; Nauwynck, H.J.; Delputte, P.L. Development and Characterization of New Species Cross-Reactive Anti-Sialoadhesin Monoclonal Antibodies. Antibodies 2016, 5, 7.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top